Literature DB >> 6786688

Assessing clinical trials--why randomise?

S M Gore.   

Abstract

Mesh:

Year:  1981        PMID: 6786688      PMCID: PMC1505821          DOI: 10.1136/bmj.282.6280.1958

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Non-randomized controls in cancer clinical trials.

Authors:  E A Gehan; E J Freireich
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

2.  Prophylaxis of postoperative leg vine thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial.

Authors:  I L Rosenberg; M Evans; A V Pollock
Journal:  Br Med J       Date:  1975-03-22

3.  Surgeon related variables.

Authors: 
Journal:  Lancet       Date:  1978-10-21       Impact factor: 79.321

4.  Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial.

Authors:  J M Henk; P B Kunkler; C W Smith
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

5.  Assessing clinical trials--design I.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

6.  Why data bases should not replace randomized clinical trials.

Authors:  D P Byar
Journal:  Biometrics       Date:  1980-06       Impact factor: 2.571

7.  The paradox of medical care.

Authors:  D Black
Journal:  J R Coll Physicians Lond       Date:  1979-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.